DURHAM, N.C. -- When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women. Researchers at the Duke Institute for Genome Sciences & Policy and the Duke Comprehensive Cancer Center may have discovered a part of the reason why, and their findings may lead to targeted therapies that can help treat patients more effectively.
